LYRA — Lyra Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Lyra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	74.6	45.7	97.9	103	40.6
Prepaid Expenses
Total Current Assets	75.9	47.9	101	105	43
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.47	5.86	4.47	35.3	21.3
Other Long Term Assets
Total Assets	80.8	54.9	110	143	66.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.88	18.2	14.5	19.6	12.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.34	20.6	29.2	53.2	54.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	74.5	34.3	80.8	89.4	11.6
Total Liabilities & Shareholders' Equity	80.8	54.9	110	143	66.3
Total Common Shares Outstanding